NCT06823570 Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.
| NCT ID | NCT06823570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Heinrich-Heine University, Duesseldorf |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-04-01 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, monocentric, randomized controlled trial to investigate the effect of anti-hypertensive treatment and/or individualized exercise training intervention on blood pressure and vascular health. Furthermore the investigators want to decipher mechanisms, which contribute to vascular health by analyzing changes in metabolism and cell function in relation to vascular reaction.
Eligibility Criteria
Inclusion Criteria: \- systolic hypertension grade I-II (BP values \>140 mmHg to \<180 mmHg) without anti-hypertensive medication treatment Exclusion Criteria: * no written informed consent * age \<18 years * isolated diastolic hypertension * medical contraindications for the exercise treatment (for example orthopedic problems or an abnormal ECG during the cardio respiratory exercise test) * chronic eye diseases on both eyes (for example macular degeneration or glaucoma) or high intraocular pressure (\>20 mmHg)
Contact & Investigator
Johannes Stegbauer, Prof. Dr.
✉ Studienzentrum-Nephrologie@med.uni-duesseldorf.de📞 +49 211 81 080 74
Frequently Asked Questions
Who can join the NCT06823570 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06823570 currently recruiting?
Yes, NCT06823570 is actively recruiting participants. Contact the research team at Studienzentrum-Nephrologie@med.uni-duesseldorf.de for enrollment information.
Where is the NCT06823570 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT06823570 clinical trial?
NCT06823570 is sponsored by Heinrich-Heine University, Duesseldorf. The trial plans to enroll 60 participants.